Last reviewed · How we verify
NCT05959538: BRIDGE
Building Regulation in Dual Generations 2022-2025
NA trial testing Building Regulation in Dual Generations (BRIDGE) in Maternal Depression in 197 participants. Completed in 16 December 2024.
26 June 2024
Quick facts
| Lead sponsor | University of Manitoba |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 197 |
| Start date | 28 October 2022 |
| Primary completion | 26 June 2024 |
| Estimated completion | 16 December 2024 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Building Regulation in Dual Generations (BRIDGE)
- Dialectical Behavioural Therapy Skill Training
Conditions studied
- Maternal Depression — all drugs for Maternal Depression →
- Self-Regulation, Emotion — all drugs for Self-Regulation, Emotion →
- Child Mental Disorder — all drugs for Child Mental Disorder →
- Child Development — all drugs for Child Development →
Sponsor
University of Manitoba
Who can join
18 and older, any sex, with Maternal Depression or Self-Regulation, Emotion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized control trial aims to investigate whether a novel intervention, the "Building Regulation in Dual Generations (BRIDGE)" program, improves mental wellness and parenting practices among mothers of 3 to 5-year-old children who have elevated symptoms of depression. The main two questions this study aims to answer are: * Does participation in the BRIDGE program reduce maternal depression symptoms? * Does participation in the BRIDGE program improve children's mental health? Researchers will compare the BRIDGE intervention to an established mental health intervention (i.e., Dialectical Behaviour Therapy skills group) and to a services-as-usual control group to see if participation in BRIDGE leads to greater improvements than either the general mental health treatment or community services as usual. Participants will: * Complete a set of questionnaires pre- and post-intervention, and at 6-month follow-up. * Complete a virtual assessment with their child at pre- and post-intervention. * Be randomized to BRIDGE, Dialectical Behavioural Therapy(DBT) skills group, or a services-as-usual control group. * Participate in the 16-week BRIDGE or DBT Skills only group, if randomized to either of these groups. If they are randomized to services-as-usual they will receive a list of community resources they can access. * Complete weekly symptom monitoring via questionnaires, if randomized to BRIDGE or DBT Skills * Wear a Fitbit device during pre- and post-intervention, as well as throughout the 16-week intervention period.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Protocol for a randomized control trial of the Building Regulation in Dual Generations Program (BRIDGE): preventing the intergenerational transmission of mental illness in at-risk preschool children.
Penner-Goeke L, Belows M, Kristjanson A, Andrade BF, et al · · 2023 · PMID 37726821 · DOI 10.1186/s13063-023-07591-8 -
Protocol for a randomized control trial of the Building Regulation in Dual Generations Program (BRIDGE); Preventing the intergenerational transmission of mental illness in at-risk preschool children
Penner-Goeke L, Belows M, Kristjanson A, Andrade BF, et al · · 2023 · DOI 10.21203/rs.3.rs-3200761/v1
Verify or expand the search:
- PubMed search for NCT05959538
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Maternal Depression
Currently open trials in the same condition.
- NCT07083037 — Enhancing Preschool Children's Attention and Behaviour: Parent-Focused Program · NA · recruiting
- NCT04092010 — Improving Preschool Outcomes by Addressing Maternal Depression in Head Start · NA · recruiting
Other University of Manitoba trials
Trials by the same sponsor.
- NCT07528417 — Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX) · Phase 2 · not yet recruiting
- NCT07366515 — Feasibility of a Multimodal Virtual Reality Intervention to Reduce Preoperative Anxiety in Cancer Surgery Patients · NA · not yet recruiting
- NCT07354386 — Effects of Dried Whole Fruits on Metabolism in Diabetes · NA · enrolling by invitation
- NCT07361315 — Development and Online Evaluation of an Online Course for Parasomnias · NA · recruiting
- NCT07023744 — CANnabinoids for Drug Resistant Epilepsy (DRE) in Adults and Children · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05959538 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Manitoba
- Last refreshed: 6 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05959538.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing